Ignite Creation Date:
2025-12-24 @ 7:15 PM
Ignite Modification Date:
2026-01-19 @ 11:19 AM
Study NCT ID:
NCT00777803
Status:
COMPLETED
Last Update Posted:
2012-03-08
First Post:
2008-10-21
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
NT 201 (Xeomin®/Bocouture®) in Comparison With Clostridium Botulinum Toxin Type A in the Treatment of Glabellar Frown Lines
Sponsor:
Merz Pharmaceuticals GmbH
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
MRZ 60201 GL_3002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None